United Kingdom · Venture startup

Who invested in EUSA Pharma

4 rounds we have observed, with the 23 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$54Mraised across 4 rounds since 2005, from 4 sources

$14MVenture$13MVenture$19MVenture$9.1MVenture
Latest round
Venture, $9.1MJun 2007
Biggest round
$19MVenture · Nov 2006
Investors
23
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20062007
$14MVenture$13MVenture$19MVenture$9.1MVenture
First round
Venture, $14M
Jul 2005
Biggest round
$19M
Venture · Nov 2006
Usual gap between rounds
8 months
the median of 3

The rounds

  1. Jun 2007
    Venture$9.1M3 new4 returning

    From a historical funding record

  2. Nov 2006
  3. Dec 2005
  4. Jul 2005
    Venture$14M2 new

    From a historical funding record

Founders and team

From EUSA Pharma's own website: 12 on the team.

  • Robert KoremansChief Executive Officer
  • Alessandra AbateGroup Chief People and Culture Officer
  • Bibianne BonGroup Chief Legal Officer
  • Lucia AbbatantuoniChief of Staff
  • Mike McClellanChief Financial Officer
  • Alberto MartinezExecutive VP Specialty & Primary Care Business Unit
  • Alessandro GilioExecutive VP Group Industrial Operations
  • Gabriele FinziExecutive VP Corporate Development & Licensing
  • Scott PescatoreExecutive VP Rare Diseases Business Unit
  • Laura ContiGroup Communications Director
  • Silvia SignorettiGroup Corporate Law Counsel and Secretary
  • Stefania PesceESG Manager

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Exits

ExitBuyerPriceWhen
AcquiredJazz Pharmaceuticals$650MApr 2012
AcquiredEUSA Pharma$23MMar 2008

From historical deal records. Wrong? Tell us.

Everyone who backed them

OrbiMedPrivate equity3rounds
Iroquois CapitalHedge fund2rounds
Hudson Bay Capital ManagementAsset manager2rounds
Heights Capital ManagementInvestment firm2rounds
Fort Mason CapitalInvestment firm2rounds
Perceptive AdvisorsAsset manager1round
J.P. Morgan Securities Inc.Investment bank1round
Merlin BiomedGrowth equity1round
Downsview CapitalVC firm1round
Banc of America SecuritiesGrowth equity1round
Alexandra Investment ManagementInvestment firm1round
Bristol Capital Advisors, LLCInvestment firm1round
Clarion Capital PartnersPrivate equity1round
Rodman & RenshawPrivate equity1round
Acqua Wellington Asset Managementno record of our own yet1round
First Eagleno record of our own yet1round
Little Gem Life Sciences Capital Managementno record of our own yet1round
Oppenheim Pramerica Asset Managementno record of our own yet1round
RG Capital Managementno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about EUSA Pharma

Who invested in EUSA Pharma?

EUSA Pharma's investors include OrbiMed, Iroquois Capital, Hudson Bay Capital Management, Heights Capital Management and Highbridge Capital Management, and 18 more on record.

How much has EUSA Pharma raised?

EUSA Pharma has raised $54M across 4 rounds since 2005.

When did EUSA Pharma last raise?

EUSA Pharma's most recent round was a Venture of $9.1M in Jun 2007.

What was EUSA Pharma's biggest round?

EUSA Pharma's largest round on record is $19M (Venture), in Nov 2006.

Who backed EUSA Pharma first?

EUSA Pharma's first round on record, in Jul 2005, was backed by OrbiMed and ProQuest Investments.

What stage is EUSA Pharma at?

EUSA Pharma's latest named round is a Venture, in Jun 2007.

Where is EUSA Pharma based?

EUSA Pharma is based in the United Kingdom.

Companies like EUSA Pharma

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.